Salvianolic Acid A Attenuates Lipopolysaccharide‐Induced Acute Lung Injury by Activating AMPK/SIRT1/Nrf2 Signaling Pathway
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Pengwei Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Sirtuin 1, Lipopolysaccharides, Acute Lung Injury. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: This study was supported by the Medical Science and Technology Research Project of Henan Province (Grant No. LHGJ20210525) and the Medical Key Subjects of Hena…, Medical Foundation.
Abstract (Originalsprache)
Salvianolic acid A (Sal A) has been reported to have anti‐inflammatory and antioxidant properties. The present study aimed to explore the potential mechanisms of Sal A on lipopolysaccharide (LPS)‐induced acute lung injury (ALI). The results indicated that Sal A pretreatment attenuated LPS induced lung injury, shown by alleviated histopathological damage and alveolar‐capillary barrier dysfunction, as well as reduced inflammatory response and oxidative stress. Moreover, Sal A pretreatment effectively increased the expression of p‐AMPK and SIRT1 and promoted Nrf2 nuclear translocation in lung tissues. However, these effects were remarkably blunted by Compound C. Molecular docking experiments further confirmed that Sal A bound well to the active sites of AMPK and SIRT1. In conclusion, these results indicated that Sal A exerted its protective effects on LPS‐induced ALI through suppressing inflammation and oxidative stress, which was mainly dependent on the activation of AMPK/SIRT1/Nrf2 signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.
- Xinxiang Key Laboratory for Individualized Drug Use Research for Immune Diseases, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.
- Clinical Pharmacy, Henan Province Key subjects of Medicine, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.
- College of Pharmacy, Xinxiang Medical University, Xinxiang, China.
- Life Science Research Center, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.
- Department of Ultrasound, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.
Förderung
- This study was supported by the Medical Science and Technology Research Project of Henan Province (Grant No. LHGJ20210525) and the Medical Key Subjects of Hena…
- Medical Foundation
Zitieren
APA
Wang, P., Sun, Y., Zhang, R., Guo, Y., Zhang, Y., Guo, S., Wang, Y., Gao, J., Yang, P., & Deng, Z. (2025). Salvianolic Acid A Attenuates Lipopolysaccharide‐Induced Acute Lung Injury by Activating AMPK/SIRT1/Nrf2 Signaling Pathway. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70282
Vancouver
Wang P, Sun Y, Zhang R, Guo Y, Zhang Y, Guo S, et al. Salvianolic Acid A Attenuates Lipopolysaccharide‐Induced Acute Lung Injury by Activating AMPK/SIRT1/Nrf2 Signaling Pathway. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70282
BibTeX
@article{Wang2025,
author = {Wang, Pengwei and Sun, Yu and Zhang, Ru and Guo, Yongli and Zhang, Yongheng and Guo, Shengjie and Wang, Yemin and Gao, Jianlian and Yang, Pengfei and Deng, Zhijian},
title = {Salvianolic Acid A Attenuates Lipopolysaccharide‐Induced Acute Lung Injury by Activating AMPK/SIRT1/Nrf2 Signaling Pathway},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70282}
}
EUVIMED